Search results for: 'formulation development outsourcing'
- Related search terms
- developments in the european smart thermostats market present strong opportunities for growth
- outsourcing services market colombia
- development startup and future trend of ophthalmic drugs market
- development states and future trend of ophthalmic drugs market
- development startup ad future trend of ophthalmic drugs market
-
18 Dec 2023  |  Global  |  Tracker
Customer Experience Outsourcing Services in Europe, Forecast to 2029
Economic Headwinds and Generative AI Impact the Future Growth Potential of CX Outsourcing
Growth rates for the European customer experience (CX) outsourcing market have declined from the double-digit pace of 2020 and 2021, partly due to economic headwinds such as rising interest rates and fluctuating exchange rates. Moderate growth is expected between 2023 and 2025, with a recovery expected to start in 2026. The introduction of generati...
$6,000.00
Special Price $4,500.00 save 25 %
-
17 Nov 2025  |  Global  |  Technology Research
Growth Opportunities in the Development of Water-Free Formulations in Personal Care and Cosmetics
Advanced Encapsulation Technology and Solid Format Products to Drive Transformational Growth
The personal care and beauty industry is undergoing a significant transformation driven by resource efficiency, consumer demand, and a focus on sustainability. Traditionally, water has been a dominant ingredient in personal care and cosmetics products, comprising up to 60 to 95% of the formulations in products such as shampoos and creams, acting as...
$4,950.00 -
11 Dec 2025  |  Global  |  Technology Research
Growth Opportunities in AI-Enhanced Formulation Strategies for Optimized Performance in Advanced Materials
Enabling Predictive and Sustainable Formulation Strategies Through AI-Powered Materials Optimization
AI-enhanced formulation transforms how advanced materials are designed, optimized, and commercialized, shifting from empirical experimentation to predictive, data-driven discovery. By combining AI, ML, and materials informatics, formulators can simulate and optimize complex multi-component systems, accelerating performance tuning, improving sustain...
$4,950.00 -
22 Aug 2024  |  Global  |  Frost Radar
Frost Radar™: Economic Development, 2024
The United States, Switzerland, and Germany are Global Frontrunners as Sustainability, Manufacturing Competitiveness, and Industry 5.0 Take Center Stage
With persistent geopolitical tensions and the resultant trade fragmentation continuing to shape the global economy, policy priorities among countries advanced and emerging are shifting toward macroeconomic frameworks that will insulate them from external shocks. Incremental reforms that support sustainability and Industry 5.0 practices will have pr...
$4,950.00
Special Price $4,207.50 save 15 %
-
19 Feb 2024  |  Global  |  Market Research
Innovations in Small Molecule Drug Delivery and Formulation
Disruptive Technologies Drive Growth Opportunities for New Product Launches
Small molecules, which are the leading drug class across indications, face several issues that threaten their drug delivery efficacy. They suffer from off-target effects, poor bioavailability, low solubility, systemic toxicity, and poor permeability. While the small molecule drug development pipeline remains a leading therapeutic class, it is essen...
$4,950.00
Special Price $3,712.50 save 25 %
-
13 Oct 2023  |  Global  |  Market Research
Global Outsourced Semiconductor Assembly and Test Growth Opportunities
Increasing Adoption of Advanced Packaging and the Need for Cost-effective ATP Solutions will Fuel Transformational Growth
This study analyzes the global outsourced semiconductor assembly and test (OSAT) market, which is set to experience substantial growth driven by the increasing adoption of advanced packaging technology across various industries. OSATs are third-party providers that specialize in assembly, testing, and packaging (ATP) services and cater to integrate...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Feb 2024  |  Global  |  Market Research
Innovation Waves in Immuno-oncology Therapy Development
Next-gen Cell Therapies and Precision Immunotherapies are Driving Growth and New Product Development
Immuno-oncology (I-O) therapies target tumors by harnessing the host s immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, includ...
$4,950.00
Special Price $3,712.50 save 25 %
-
13 Dec 2021  |  Global  |  Technology Research
Technology Enablers Facilitating Microbiome Adoption in Research and Development
Advancements in Analytical Methods and Digital Tools Fuel Growth Opportunities in Microbiome Research and Product Development
Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...
$4,950.00
Special Price $3,712.50 save 25 %
-
18 May 2026  |  Global  |  Frost Radar
Frost Radar™: Smart Delivery Formulations for Biologics, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Biologics, particularly peptide and protein therapies, are a rapidly growing therapeutic area because they can target complex biological pathways with high efficacy. These therapies are becoming important in oncology, metabolic disease, and autoimmune conditions supported by the growing global disease burden and growth in areas such as GLP-1s and m...
$4,950.00 -
25 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development and Manufacturing Organizations, 2024 2029
Risk-sharing Business Models for Next-generation Biologics Will Drive Bio-CDMO Growth and Spur Future Potential
By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...
$4,950.00
Special Price $3,712.50 save 25 %